Skip to content

The study of precise transcranial magnetic stimulation (TMS) guided by imaging in the rehabilitation therapy of dysphagia after stroke

The study of precise transcranial magnetic stimulation (TMS) guided by imaging in the rehabilitation therapy of dysphagia after stroke

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2600126003
Enrollment
Unknown
Registered
2026-06-02
Start date
2026-06-08
Completion date
Unknown
Last updated
2026-06-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

The motor-TMS group:In the M1 area, apply the iTMS stimulation once a day, 5 times a week, for a total of 2 weeks.
The sensory-TMS group:In the S1 area, apply the iTMS stimulation once a day, 5 times a week, for a total of 2 weeks.
The sham-TMS group:In the M1 area, a sham stimulus was administered once a day, 5 times a week, for a total of 2 weeks.

Sponsors

Beijing Boai Hospital, China Rehabilitation Research Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Age range: 18 - 80 years old; within 6 months after the onset of stroke; 2. Diagnosed with unilateral hemorrhagic or unilateral ischemic stroke by imaging examination (CT or MRI); 3. Has post-stroke dysphagia; 4. Can cooperate with the assessment and treatment and sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1. Participate in other clinical trials simultaneously; 2. Have other severe neurological diseases apart from stroke (such as Parkinson's disease, etc.); 3. Have severe physical diseases other than stroke (such as epilepsy, acute myocardial infarction, unstable angina pectoris, etc.); 4. Have contraindications for MRI examination (such as claustrophobia, intracranial metal implants, etc.); 5. Have contraindications for TMS treatment (such as cardiac pacemakers, intracranial metal implants, large-area skull defects on the affected side, etc.).

Design outcomes

Primary

MeasureTime frame
Permeation Aspiration Scale;

Secondary

MeasureTime frame
Chinese-Mann Assessment of Swallowing Ability;Water Swallowing Test;National Institutes of Health Stroke Scale;Swallowing Disorders Quality of Life;

Countries

China

Contacts

Public ContactDu Xiaoxia, Zhang Yuguo

Beijing Boai Hospital, China Rehabilitation Research Center

90zyg@163.com+86 10 8756 9420

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Jun 11, 2026